Business Description
FibroBiologics Inc. is a Houston-based medical research company founded in 2021 that uses specialized human cells called fibroblasts to create new treatments for serious long-term illnesses. Its current lineup of therapies targets conditions such as multiple sclerosis, psoriasis, degenerative disc disease, wound healing, and certain cancers, with several treatments already progressing through clinical testing. The company is also exploring how fibroblast-based science could play a role in extending healthy human life.
